What is the most effective treatment for extensive actinic keratoses in an 89‑year‑old male with hypertension controlled on lisinopril?

Treatment of Extensive Actinic Keratoses

For this 89-year-old patient with extensive actinic keratoses involving multiple sun-exposed areas (scalp, face, and arms), field-directed treatment with topical 5-fluorouracil is the most effective therapy.

Rationale for Field-Directed Treatment

This patient presents with classic field cancerization—multiple rough, scaly patches with erythematous bases across contiguous sun-exposed areas, with the dorsal forearms having a characteristic "sandpaper texture" 1. Given the extensive involvement across multiple anatomic sites, field-directed therapy is superior to lesion-directed approaches because it:

• Treats both visible and subclinical lesions within the affected field 1
• Reduces the risk of developing new actinic keratoses 1
• Addresses the underlying UV-induced DNA damage in surrounding skin 1

Primary Recommendation: 5-Fluorouracil

The American Academy of Dermatology (2021) provides a strong recommendation (moderate quality evidence) for field treatment with 5-fluorouracil 1. This is the highest strength recommendation among topical agents for extensive disease.

Why 5-Fluorouracil is Most Effective

• Superior long-term efficacy: In a large randomized trial of 624 patients, 5-fluorouracil demonstrated a 74.7% probability of remaining free from treatment failure at 12 months—significantly higher than imiquimod (53.9%), photodynamic therapy (37.7%), or ingenol mebutate (28.9%) 2
• Hazard ratios for treatment failure compared to 5-fluorouracil were 2.03 for imiquimod, 2.73 for photodynamic therapy, and 3.33 for ingenol mebutate (all P≤0.001) 2
• Flexible dosing regimens: Can be applied once or twice daily for 2-4 weeks depending on tolerance 1
• Cost-effective: Widely available and lower cost than newer agents 3

Practical Application for This Patient

For extensive involvement across scalp, face, and arms 3:

• 5-fluorouracil 0.5% cream: Apply once daily for 2-4 weeks to affected areas 1
• Alternative: 5-fluorouracil 5% cream twice daily for 2-4 weeks for thicker lesions 1
• For hyperkeratotic lesions (like the sandpaper-textured forearms): Consider 5-fluorouracil 0.5% in 10% salicylic acid, which achieved 55.4% complete clearance versus 32% with diclofenac 3

Managing Treatment Reactions

• Expected local reactions: Erythema, crusting, and soreness are common and indicate treatment efficacy 3
• Titration strategy: If reactions are excessive, reduce application frequency or take short breaks 3
• Counseling is critical: Approximately 50% of patients discontinue treatment at 6 weeks due to lesion disappearance, but completing the full course reduces recurrence 3

Alternative: Imiquimod

Imiquimod 5% cream also receives a strong recommendation (moderate quality evidence) from the American Academy of Dermatology 1. This is appropriate if 5-fluorouracil is not tolerated or contraindicated.

Imiquimod Regimen

• Apply 3 times weekly for 4 weeks, which can be repeated for another 4 weeks if needed 3
• Achieves approximately 50% complete clearance rate 3
• Superior long-term maintenance: In one study, 76% of patients maintained clearance at 12 months versus 33% with 5-fluorouracil, though this study had methodological concerns with the cryosurgery arm 3

Role of Cryosurgery

Cryosurgery receives a strong recommendation but is impractical as monotherapy for this patient's extensive disease 1. With numerous lesions across multiple large anatomic areas, treating each lesion individually would be:

• Time-consuming and require multiple office visits 1
• More painful than field-directed therapy 1
• Less effective at preventing new lesions in the surrounding field 1

Combination approach: Consider cryosurgery for any particularly thick or treatment-resistant lesions after completing field therapy 1.

Special Considerations for This Patient

Age and Limited Life Expectancy

At 89 years old, the guidelines acknowledge that observation may be considered for patients with limited life expectancy or when treatment morbidity outweighs benefits 1. However, treatment is still reasonable because:

• Actinic keratoses can be symptomatic (pruritus, tenderness) 1
• Risk of progression to squamous cell carcinoma exists, though low per individual lesion 1
• Field-directed therapy can be completed in 2-4 weeks with manageable side effects 3

Medication Interactions

Lisinopril (Zestril) does not interact with topical actinic keratosis treatments 4. The only topical agent with a relevant warning is diclofenac gel, which carries an NSAID black box warning for cardiovascular and gastrointestinal effects, though systemic absorption from topical application is minimal 1.

Treatments to Avoid or Deprioritize

• Diclofenac gel: Only a conditional recommendation with low-quality evidence; less effective than 5-fluorouracil or imiquimod 1
• Photodynamic therapy: Conditional recommendation; requires office visits, is more expensive, and showed inferior long-term efficacy compared to 5-fluorouracil 1, 2
• Ingenol mebutate: Demonstrated the poorest long-term efficacy in head-to-head trials 2

Prevention and Long-Term Management

• UV protection is strongly recommended as a good practice statement 1
• Recurrence is common: Up to 50% within the first year 1
• Repeat field treatment may be needed for new lesions or recurrence 3
• Surveillance: Monitor for development of squamous cell carcinoma, particularly in previously treated areas 1

Common Pitfalls

• Inadequate counseling about expected reactions: Patients must understand that erythema and crusting indicate efficacy, not treatment failure 3
• Premature discontinuation: Completing the full treatment course is essential for optimal outcomes 3
• Treating only visible lesions: Field therapy addresses subclinical damage and reduces future lesion development 1
• Poor healing sites: Use caution on lower legs where healing may be impaired; this patient's lesions are on the scalp, face, and arms where healing is typically good 3